Anesthesia Quality Institute Announces BD as New Corporate Supporter

CHICAGO – The Anesthesia Quality Institute (AQI), a related organization of the American Society of Anesthesiologists (ASA), today announced that leading global medical technology company, BD (Becton, Dickinson and Company) (NYSE: BDX), has joined AQI’s Corporate Supporter Program to support the enhancement of how anesthesia data are collected and used to improve patient care.

“We welcome BD as a new AQI corporate supporter and are excited to be working with them on this quality-driven initiative to transform data collection, analysis, and reporting of anesthesia care nationally,” said AQI Board of Directors Chair Randall M. Clark, M.D., FASA. “AQI and BD share a mutual commitment toward enhancing patient safety and outcomes. Through our collaboration, we’ll be able to collect more complete and granular anesthesia and perioperative data, which will help to advance patient care and improve outcomes.”

BD’s support will directly impact the development of the first-of-its-kind, electronic health record-derived Anesthesia Community Registry (ACR), being developed by AQI in collaboration with Epic, and enhancements to AQI’s National Anesthesia Clinical Outcomes Registry (NACOR), the largest anesthesia registry in the country. The ACR and NACOR will work in tandem to allow a more robust collection and reporting system with much greater ease of use compared to current methods.

“At BD, we are committed to advancing the world of health by improving patient safety and outcomes through innovation and collaboration,” said Tim Patz, worldwide president, BD Advanced Patient Monitoring. “Partnering with AQI on initiatives like the Anesthesia Community Registry and enhancements to the National Anesthesia Clinical Outcomes Registry reflects our shared vision to leverage data-driven insights that empower clinicians and elevate the quality of anesthesia care nationwide.”

Launched in 2025, AQI’s Corporate Supporter Program is intended for companies who want to stand apart by demonstrating a high-level of commitment to improving patient care, informing data collection and reporting that impacts the anesthesia community, and participating in collaborative research that advances patient safety, anesthesiology practice and innovation.

About the American Society of Anesthesiologists
Founded in 1905, the American Society of Anesthesiologists (ASA) is an educational, research and scientific society with more than 60,000 members organized to advance the medical practice of anesthesiology and secure its future. ASA is committed to ensuring anesthesiologists evaluate and supervise the medical care of all patients before, during and after surgery. ASA members also lead the care of critically ill patients in intensive care units, as well as treat pain in both acute and chronic settings.

For more information on the field of anesthesiology, visit the American Society of Anesthesiologists online at asahq.org. To learn more about how anesthesiologists help ensure patient safety, visit asahq.org/madeforthismoment. Follow ASA on Facebook, X, Instagram, Bluesky, and LinkedIn.

About the Anesthesia Quality Institute
The Anesthesia Quality Institute (AQI) was established by the American Society of Anesthesiologists (ASA) in 2008 to facilitate practice-based quality management through education and quality data feedback. AQI helps to improve the quality care of patients, lower anesthesia mortality and lower anesthesia incidents. The AQI is a Patient Safety Organization (PSO) and home to NACOR, the largest anesthesia registry in the world. NACOR is also a Qualified Registry (QR) and a Qualified Clinical Data Registry (QCDR).

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

#          #          #